MARKET

FEMY

FEMY

FEMASYS INC
NASDAQ
1.100
+0.020
+1.85%
Closed 19:52 05/13 EDT
OPEN
1.070
PREV CLOSE
1.080
HIGH
1.110
LOW
1.060
VOLUME
97.41K
TURNOVER
0
52 WEEK HIGH
1.800
52 WEEK LOW
0.8600
MARKET CAP
29.96M
P/E (TTM)
-1.3018
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at FEMY last week (0505-0509)?
Weekly Report · 1d ago
Femasys Is Maintained at Buy by HC Wainwright & Co.
Dow Jones · 4d ago
Femasys Price Target Cut to $12.00/Share From $15.00 by HC Wainwright & Co.
Dow Jones · 4d ago
Analyst Expectations For Femasys's Future
Benzinga · 4d ago
HC Wainwright & Co. Maintains Buy on Femasys, Lowers Price Target to $12
Benzinga · 4d ago
Femasys’s Growth Potential Highlighted by U.S. Revenue Surge and Strategic Partnerships
TipRanks · 4d ago
FEMASYS INC. <FEMY.O>: H.C. WAINWRIGHT CUTS TARGET PRICE TO $12 FROM $15
Reuters · 4d ago
U.S. RESEARCH ROUNDUP-Certara, Curtiss-Wright, McKesson
Reuters · 5d ago
More
About FEMY
More
Femasys Inc. is a biomedical company. The Company is focused on addressing the unmet needs of women worldwide with a broad portfolio of in-office, accessible, and therapeutic and diagnostic solutions. The Company has two lead product candidates: FemBloc and FemaSeed. FemBloc is a permanent birth control solution in development. Its permanent birth control solution in development includes its FemBloc system, which features dual intrauterine directional delivery targeting both fallopian tubes with a degradable blended biopolymer. FemaSeed is an artificial insemination infertility treatment. Its artificial insemination solution in development includes its FemaSeed product candidate for artificial insemination, which features single intrauterine directional delivery. It also developed FemCerv, which is an endocervical tissue sampler for cervical cancer diagnosis; FemVue, which is a companion diagnostic for fallopian tube assessment; FemCath, which is an intrauterine catheter, and FemChec.
Recently
Symbol
Price
%Change

Webull offers Femasys Inc stock information, including NASDAQ: FEMY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, FEMY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading FEMY stock methods without spending real money on the virtual paper trading platform.